داروسازی ابوریحان
دابور | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 65,540 2.99
Close Price: 65,560
Income Statement
AGM
Interim
2026/06/29 Fiscal Year 2026/03/2012 Month | 2025/06/08 Fiscal Year 2025/03/2012 Month | 2024/05/14 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 33.862 Trillion | 16.41 Trillion | 14.135 Trillion | |
Total Revenues | 33.862 Trillion | 16.41 Trillion | 14.135 Trillion | |
Cost of Goods Sold | 15.885 Trillion | 9.943 Trillion | 8.438 Trillion | |
Gross Profit | 17.977 Trillion | 6.467 Trillion | 5.697 Trillion | |
General & Administrative Expenses | 1.752 Trillion | 979.311 Billion | 909.104 Billion | |
Net Operating Income & Expenses | -438.249 Billion | -129.523 Billion | 28.843 Billion | |
Operating Profit (Loss) | 15.787 Trillion | 5.358 Trillion | 4.816 Trillion | |
Profit Before Tax | 13.8 Trillion | 2.998 Trillion | 2.571 Trillion | |
Tax | 2.788 Trillion | 793.516 Billion | 717.42 Billion | |
Net Profit (Loss) After Tax | 11.012 Trillion | 2.204 Trillion | 1.853 Trillion | |
Retained Earnings at Beginning of Period | 2.204 Trillion | 2.364 Trillion | 4.979 Trillion | |
Approved Dividends — Prior Year AGM | -1.15 Trillion | -1.8 Trillion | -4.48 Trillion | |
Transfer from Other Equity Items | - | 1.188 Billion | 12.386 Billion | |
Allocable Profit | 12.066 Trillion | 2.77 Trillion | 2.364 Trillion | |
Approved Dividends — Current Year | 5.994 Trillion | 1.15 Trillion | 1.8 Trillion | |
Retained Earnings at End of Period | 6.072 Trillion | 1.619 Trillion | 563.988 Billion |